Regular monitoring and evaluation are recommended for patients with hypertrophic cardiomyopathy (HCM)1,2

  • Patients should be monitored and evaluated at a frequency that is determined by the severity of their disease, age, and symptoms.1*

An electrocardiogram and an echocardiogram should be performed every 1 to 2 years or sooner if patients complain of new heart failure symptoms1,3

24-hour ambulatory (Holter) electrocardiogram is recommended every 1 to 2 years in patients with HCM who have no previous evidence of ventricular tachycardia1-3

Cardiopulmonary exercise testing (which includes parameters such as ventilatory efficiency and anaerobic threshold) with simultaneous measurement of respiratory gases (e.g., peak oxygen consumption [pVO2]) can provide objective evidence for worsening disease and may be considered every 2 to 3 years1,3

Other measures to evaluate treatment and follow patients with symptomatic HCM/obstructive HCM include:

  • Left ventricular outflow tract (LVOT) gradient1,3
  • Reduction in physical limitations1
  • Symptomatic improvement3

HCM can continue to progress
even in asymptomatic patients

Monitoring is recommended
and should increase in
frequency based on symptoms,
age and severity of disease1,3

Ongoing monitoring and evaluation of patients can determine if HCM is progressing1-3

Footnote

Hide references

* Utilize your institutional practice guidelines for the management and monitoring of patients with HCM.

References

Hide references
  1. Ommen SR, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;142(25):e558-e631.
  2. Gersh BJ, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2011;142(6):e153-203.
  3. Naidu, Srihari S, editor. Hypertrophic Cardiomyopathy. Second ed., Springer International Publishing, 2019.